ПРИМЕНЕНИЕ ПРОГРАММЫ «СПУТНИК» ДЛЯ ПРИВЛЕЧЕНИЯ НАИМЕНЕЕ ПРИВЕРЖЕННЫХ ПАЦИЕНТОВ К ЛЕЧЕНИЮ
doaj
[Clinical polymorphism of primary hyperparathyroidism in children]. [PDF]
Benina AR +3 more
europepmc +1 more source
[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development]. [PDF]
Ermolaeva AS, Fadeev VV.
europepmc +1 more source
[Differentiated thyroid carcinoma in children and adolescents]. [PDF]
Nagaeva EV +13 more
europepmc +1 more source
[Study of accuracy assessment of the Gmate LIFE blood glucose monitoring system]. [PDF]
Bybin VA, Bykova NM, Kharitonova EA.
europepmc +1 more source
[Dual-energy CT for differential diagnosis of adrenal lesions]. [PDF]
Tarbaeva NV +7 more
europepmc +1 more source
[Level of reactive oxygen species production in peripheral blood monocytes in patients with Graves' disease after radioiodine therapy]. [PDF]
Fomina DV +3 more
europepmc +1 more source
[Highly selective sodium-glucose co-transporter type 2 inhibitor empagliflozin as means of brain protection in conditions of chronic brain dyscirculation]. [PDF]
Simanenkova AV +7 more
europepmc +1 more source
[Switching patients from cinacalcet to etelcalcetide: evaluation of predictors of efficacy in a retrospective cohort study]. [PDF]
Parshina EV +3 more
europepmc +1 more source
[Clinical, hormonal and molecular genetic characteristics of patients with 46,XY disorders of sex development associated with variants in the HSD17B3 gene]. [PDF]
Kalinchenko NY +5 more
europepmc +1 more source

